Both in Pharmaceuticals
SELLAS Life Sciences Group vs Agios Pharmaceuticals
Over the past year SLS returned +450.6% and AGIO returned −21.6%; their daily moves had a correlation of 0.13.
SLS +450.6% AGIO −21.6%Growth of $1, one year, split-adjusted
| Metric | SLS | AGIO |
|---|---|---|
| Price | $9.14 | $31.38 |
| Market cap | $1.85B | $1.87B |
| Today | +3.04% | +0.58% |
| 1 month | −19.4% | −1.1% |
| 6 months | +77.5% | +16.3% |
| Year to date | +142.4% | +15.3% |
| 1 year | +410.6% | −21.8% |
| Revenue growth (YoY) | — | +259.3% |
| Gross margin | — | 93.3% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 19.1× |
| Net cash | $138.3M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 97.0% | 58.0% |
| Short % of float | 27.0% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).